Literature DB >> 8768540

[Pharmaceutical expenditure in primary care according to the prescription source].

J A Lomeña Villalobos1, M Ceballos Vacas, M T Medina Arteaga, E Mediavilla Cordero, F Sarmiento Jiménez, J L Hernández Grande.   

Abstract

OBJECTIVE: To find the origin of primary care pharmaceutical prescription and where expenditure is attributed.
DESIGN: A descriptive study of a prospective character.
SETTING: Medical clinics of a primary care team at the Torre del Mar Health Centre, Málaga. MAIN
RESULTS: A total of 2,580 prescriptions, whose average price was 1,415.4 pesetas, with a range from 135 to 35,889 pesetas, were issued. An average of 143.3 prescriptions a day were issued during the days analysed. The number of prescriptions issued by PC itself made up more than half the prescriptions, similar to the number of prescriptions originating elsewhere. The average price is greater for outside prescriptions than for prescriptions from within PC. Total accumulated cost was 3,651,912 pesetas. Expenditure on outside prescriptions was 1,774,783 pesetas, 48.59% of total cost. Total cost of prescriptions from within PC was 1,733,701 pesetas, 47.47% of the total.
CONCLUSIONS: PC has been assigned the role of issuing most prescriptions in the health-care system. This causes various problems within PHC: 1) a major administrative overload; 2) a great imaginative effort to try to avoid bureaucratic burdens; and 3) a real ability to rationalise the offer of medicines using quality criteria of only about 50%, as the other 50% of medicines originates outside PHC. We believe an extension of the programmes to guarantee quality in specialist care is needed, particularly of those programmes relating to pharmaceutical prescription.

Entities:  

Mesh:

Year:  1996        PMID: 8768540

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  3 in total

1.  The cost of inadequate prescriptions for hypolipidaemic drugs. VICAF Group.

Authors:  L C Ballesteros; M I Fernández San Martín; T Sanz Cuesta; E Escortell Mayor; C López Bilbao
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  [How much do medicines that are thrown away cost?].

Authors:  J Salgado Ramos; R Maeso Corroto; S Machín Hamalainen; E Tapias Merino
Journal:  Aten Primaria       Date:  2004 Jul-Aug       Impact factor: 1.137

3.  [At what care level are cyclo-oxygenase-2 inhibitors prescribed?].

Authors:  M J Montero Fernández; F J Rodríguez Alcalá; N Valles Fernández; F López de Castro; M Esteban Tudela; B Cordero García
Journal:  Aten Primaria       Date:  2002-10-15       Impact factor: 1.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.